Patents Assigned to PERORA GMBH
  • Patent number: 11504330
    Abstract: The invention provides ingestible particles comprising a water-swellable or water-soluble polymeric component, a lipid component, and optionally an amino acid, a vitamin and/or a micro-nutrient. The polymeric component may be embedded in the lipid component. The particle may further comprise an inert core and/or an outer layer which rapidly disintegrates after oral ingestion. The invention further provides methods for preparing the ingestible particles and uses thereof.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: November 22, 2022
    Assignee: PERORA GMBH
    Inventor: Dirk Vetter
  • Patent number: 11311570
    Abstract: The invention provides a method of inducing satiety in a subject comprising a step of orally administering a composition comprising an effective amount of a first agent capable of inducing satiety and of a second agent capable of augmenting the satiety-inducing effect of the first agent. Also disclosed are compositions for carrying out the method, and a body weight management system comprising such compositions in combination with a device configured for the collection, storage and/or display of information relating to a subject's response to a predefined therapeutic regimen of orally administering the composition.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: April 26, 2022
    Assignee: PERORA GMBH
    Inventor: Dirk Vetter
  • Patent number: 11234935
    Abstract: The invention provides a method of inducing satiety in a subject comprising a step of orally administering a composition comprising an effective amount of a first agent capable of inducing satiety and of a second agent capable of augmenting the satiety-inducing effect of the first agent. Also disclosed are compositions for carrying out the method and a body weight management system comprising such compositions in combination with a device configured for the collection, storage and/or display of information relating to a subject's response to a predefined therapeutic regimen of orally administering the composition.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: February 1, 2022
    Assignee: PERORA GMBH
    Inventor: Dirk Vetter